Magnetic Mini-Mover Procedure to Treat Pectus Excavatum (3MP)
Pectus Excavatum
About this trial
This is an interventional treatment trial for Pectus Excavatum focused on measuring pectus excavatum, magnetic alteration, chest wall deformity
Eligibility Criteria
Residents of the United States with previously diagnosed pectus excavatum who are referred to the UCSF Pediatric Surgery Service for evaluation and treatment will be considered for participation in this study. Only patients with moderate to severe pectus excavatum who meet all the inclusion criteria will participate. The patient and family will be fully counseled and consented about the risks and benefits of participation in the study, and will be asked to sign an informed consent reviewed and approved by the UCSF Committee on Human Research.
Inclusion Criteria:
- Resident of the U.S.;
- Otherwise healthy male or female with pectus excavatum deformity;
- Between 8 and 14 years of age;
- Pectus Severity Index > 3.5 (normal 2.56); and
- Ability to read and speak English.
Exclusion Criteria:
- Other congenital anomalies (including significant skeletal anomalies such as scoliosis, bony fusion involving the cervical vertebrae) not directly related to pectus excavatum;
- Bleeding disorders;
- Heart disease (including arrhythmia);
- Persons with active implantable medical devices (AIMD) such as pacemakers;
- Persons with a relative(s) or close family friend(s) living within their households and having a pacemaker;
- Persons with arteriovenous malformations;
- Chest deformity more complicated than pectus excavatum (e.g.. Poland syndrome);
- Persons for whom a foreign body implant would pose a risk (e.g., immunodeficiency);
- Persons at increased risk for general anesthesia (e.g., history of malignant hyperthermia);
- Respiratory conditions that have required steroid treatment (e.g., prednisone)in the last 3 years;
- Pregnancy;
- Inability to understand or follow instructions;
- Refusal to wear the external brace;
- Inability to obtain pre-approval (authorization) from the patient's insurance carrier; and
- Inability or refusal to return to UCSF for weekly follow-up visits for the first month after surgery.
Sites / Locations
- University of California, San Francisco
Arms of the Study
Arm 1
Experimental
3MP - Treatment Arm
Magnetic Mini-Mover Procedure using the Magnimplant and Magnatract